Articles 2012

Bertrand G, Bakchoul T, Javela K, Kjaer Killie M, Kaplan C and SSC of the ISTH. Interlaboratory workshop on anti-HPA-1a alloantibody quantification with the mAb-specific immobilization of platelet antigen technique. J Thromb Haemost. 2012;10(6):1172-4. PM: 22826827

Coste J, Prowse C, Grabmer C, Schennach H, Santos Prado Scuracchio P, Wendel SN, Germain M, Delage G, Krusius T, Ekblom-Kullberg S, Tiberghien P, O’Riordan J, Murphy WG, Flesland O, Turner M, Williamson L, Gregori L, Epstein J, Asher D, Panzer S and Reesink HW. Prion reduction of red-blood-cells. Vox Sang. 2012;103(3):260-72. PM: 22519941

Egyudova K, Fajtova M, Cizmar A, Korhonen M, Gyarfas J, Kankuri E and Bizik J. COX-2 expression in fibroblast aggregates as afunctional indicator for the anti-inflammatory activity of leukemia patients bone marrow-derived hematopoietic cells. Neoplasma. 2012;59(5):574-83. PM: 2266802

Eskola M, Arvola A, Juutistenaho S, Aranko K and Kekomäki R. Association of CFU-Mk with total colony-forming unitsin thawed cord blood units. Vox Sang. 2012;103(4):331-6. PM: 22725627

Ferreira RC, Pan-Hammarström Q, Graham RR, Fontan G, Lee AT, Ortmann W, Wang N, Urcelay E, Fernandez-Arquero M, Nunez C, Jorgensen G, Ludviksson BR, Koskinen S, Haimila K, Padyukov L, Gregersen PK, Hammarström L and Behrens TW. High-Density SNP Mapping of the HLA Region Identifies Multiple Independent Susceptibility Loci Associated with Selective IgA Deficiency. PLoS Genet. 2012;8(1):e1002476. PM: 22291608

Hirvonen T, Suila H, Kotovuori A, Ritamo I, Heiskanen A, Sistonen P, Anderson H, Satomaa T, Saarinen J, Tiitinen S, Räbinä J, Laitinen S, Natunen S and Valmu L. The i blood group antigen as a marker for umbilical cord blood derived mesenchymal stem cells. Stem Cells Dev. 2012;21(3):455-63. PM: 21933024

Joda H, Beni V, Curnane D, Katakis I, Alakulppi N, Partanen J, Lind K, Strömbom L and O’Sullivan CK. Low-medium resolution HLA-DQ2/DQ8 typing for coeliac disease predisposition analysis by colorimetric assay. Anal Bioanal Chem. 2012;403(3):807-19. PM: 22418762

Johnson MP, Brennecke SP, East CE, Goring HH, Kent JW,Jr, Dyer TD, Said JM, Roten LT, Iversen AC, Abraham LJ, Heinonen S, Kajantie E, Kere J, Kivinen K, Pouta A, Laivuori H, FINNPEC Study Group, Austgulen R, Blangero J and Moses EK (Collaborators: Sainio S et al) Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene. PLoS One. 2012;7(3):e33666. PM: 22432041

Karhemo PR, Ravela S, Laakso M, Ritamo I, Tatti O, Mäkinen S, Goodison S, Stenman UH, Hölttä E, Hautaniemi S, Valmu L, Lehti K and Laakkonen P. An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis. J Proteomics 2012;77:87-100. PM: 22813880

Kauppinen A, Peräsaari J, Taivainen A, Kinnunen T, Saarelainen S, Rytkonen-Nissinen M, Jeal H, Jones M and Virtanen T. Association of HLA class II alleles with sensitization to cow dander Bos d 2, an important occupational allergen. Immunobiology. 2012;217(1):8-12. PM: 21962572

Kolmeder CA, de Been M, Nikkilä J, Ritamo I, Mättö J, Valmu L, Salojärvi J, Palva A, Salonen A and de Vos WM. Comparative Metaproteomics and Diversity Analysis of Human Intestinal Microbiota Testifies for Its Temporal Stability and Expression of Core Functions. PLoS ONE. 2012;7(1):e29913. LINK

Koppelman, MH, Cuijpers HT, Wessberg S, Valkeajärvi A, Pichl L, Schottstedt V, Saldanha J. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA. Transfusion 2012;52(7):1498-508. PM: 22587637

Kreutzman A, Jaatinen T, Greco D, Vakkila E, Richter J, Ekblom M, Hjorth-Hansen H, Stenke L, Melo T, Paquette R, Seggewiss-Bernhardt R, Guerci-Bresler A, Talbot A, Cayuela JM, Mahon FX, Porkka K, Lipton J, Partanen J, Rousselot P and Mustjoki S. Killer-cell immunoglobulin-like receptor (KIR) gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia. Exp Hematol. 2012;40(11):906-13. PM: 22842045

Krusius T. The national organization in a shrinking economy. ISBT Science Series. 2012;7(1):99-101.

Krusius T. Pooled SD-pathogen inactivated FFP as an alternative to regular FFP. kirjassa: Heier, HE, Burnouf T, De Angelis V, El Ekiaby M, toimittajat. Appropriate use of plasma products. Proceedings of the ESTM residential course, Zagreb, Croatia, 14-18 November 2012: European School of Transfusion Medicine; 2012:249-251

Krusius T. Epidemiological data on use of plasma products. kirjassa: Heier, HE, Burnouf T, De Angelis V, El Ekiaby M, toimittajat. Appropriate use of plasma products. Proceedings of the ESTM residential course, Zagreb, Croatia, 14-18 November 2012: European School of Transfusion Medicine; 2012:337-343.

Kujala K, Ahola A, Pekkanen-Mattila M, Ikonen L, Kerkelä E, Hyttinen J, et al. Electrical field stimulation with a novel platform: Effect on cardiomyocyte gene expression but not on orientation. Int J Biomed Sci.2012;8(2):109-20. PM: 23675263

Kurppa K, Räsänen T, Collin P, Iltanen T,Huhtala H, Ashorn M, Saavalainen P, Haimila K, Partanen J, Mäki M, Kaukinen K. Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation. World Journal of Gastroenterology 2012;18(20):2511-16. PM: 22654448

Laiho MK, Harjola VP, Graner M, Piilonen A, Raade M and Mustonen P. Helical computerized tomography and NT-proBNP for screening of right ventricular overload on admission and at long term follow-up of acute pulmonary embolism. Scand J Trauma Resusc Emerg Med. 2012;20:33. PM: 22559861

Miettinen J, Peräsaari J, Lauronen J, Qvist E, Valta H, Pakarinen M, Merenmies J and Jalanko H. Donor-specific HLA antibodies and graft function in children after renal transplantation. Pediatr Nephrol. 2012;27(6):1011-9. PM: 21993970

Mitkari B, Kerkelä E. Nystedt J and Korhonen M. Toward a More Effective Intravascular Cell Therapy in Stroke. In: Advances in the Treatment of Ischemic Stroke Balestrino M. editors. InTech; 2012:142-60.

Mustonen P and Puurunen M. Mitä jokaisen lääkärin oli hyvä tietää uusista antitromboottisista lääkkeistä. Duodecim. 2012;128(7):707-18. PM: 22612021

Mäkikallio K, Kaukola T, Tuimala J, F Kingsmore S, Hallman M and Ojaniemi M. Umbilical artery chemokine CCL16 is associated with preterm preeclampsia and fetal growth restriction. Cytokine. 2012;60(2):377-84. PM: 22857868

Mäkivuokko H, Lahtinen SJ, Wacklin P, Tuovinen E, Tenkanen H, Nikkilä J, Björklund M, Aranko K, Ouwehand AC and Mättö J. Association between the ABO blood group and the human intestinal microbiota composition. BMC Microbiol. 2012;12(1):94. PM: 22672382

Mäkivuokko H, Wacklin P, Koenen ME, Laamanen K, Alakulppi N, Venema K and Mättö J. Isolation of bifidobacteria for blood group secretor status targeted personalised nurtition. Microbial Ecology in Health & Disease 2012;23:18578. PM: 23990829

Neu AM, Sander A, Borzych-Duzalka D, Watson AR, Valles PG, Ha IS, Patel H, Askenazi D, Balasz-Chmielewska I, Lauronen J, Groothoff JW, Feber J, Schaefer F, Warady BA and the IPPN investigators. Comorbidities in Chronic Pediatric Peritoneal Dialysis Patients: A Report of the International Pediatric Peritoneal Dialysis Network. Perit Dial Int. 2012;32(4):410-8. PM: 22859841

Parmar AS, Alakulppi N, Paavola-Sakki P, Kurppa K, Halme L, Färkkilä M, Turunen U, Lappalainen M, Kontula K, Kaukinen K, Mäki M, Lindfors K, Partanen J, Sistonen P, Mättö J, Wacklin P, Saavalainen P and Einarsdottir E. Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population. Tissue Antigens. 2012;80(6):488-92. PM: 23075394

Pastila S, Lönnroth M, Heikkilä R, Heikkilä H and Carlson P. Bacterial skin flora and contamination of blood components: do we defer blood donors wisely? Vox Sang. 2012;103(2):93-8. PM: 22348231

Pietilä M, Palomäki S, Lehtonen S, Ritamo I, Valmu L, Nystedt J, Laitinen S, Leskelä HV, Sormunen R, Pesälä J, Nordström K, Vepsäläinen A and Lehenkari P. Mitochondrial function and energy metabolism in umbilical cord blood- and bone marrow-derived mesenchymal stem cells. Stem Cells Dev. 2012;21(4):575-8. PM: 21615273

Pietilä M, Lehtonen S, Tuovinen E, Lähteenmäki K, Laitinen S, Leskelä H, Nätynki A, Pesälä J, Nordström K and Lehenkari P. CD200 Positive Human Mesenchymal Stem Cells Suppress TNF-Alpha Secretion from CD200 Receptor Positive Macrophage-Like Cells. PLoS ONE. 2012;7(2):e31671. LINK

Pietilä M, Lähteenmäki K, Lehtonen S, Leskelä HV, Närhi M, Lönnroth M, Mättö J, Lehenkari P and Nordström K. Monitoring mitochondrial inner membrane potential for detecting early changes in viability of bacterium-infected human bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther. 2012;3(6):53. PM: 23231835

Reesink HW, Lee J, Keller A, Dennington P, Pink J, Holdsworth R, Schennach H, Goldman M, Petraszko T, Sun J, Meng Y, Qian K, Rehacek V, Turek P, Krusius T, Juvonen E, Tiberghien P, Legrand D, Semana G, Muller JY, Bux J, Reil A, Lin CK, Daly H, McSweeney E, Porretti L, Greppi N, Rebulla P, Okazaki H, Sanchez-Guerrero SA, Baptista-Gonzalez HA, Martinez-Murillo C, Guerra-Marquez A, Rodriguez-Moyado H, Middelburg RA, Wiersum-Osselton JC, Brand A, van Tilburg C, Dinesh D, Dagger J, Dunn P, Brojer E, Letowska M, Maslanka K, Lachert E, Uhrynowska M, Zhiburt E, Palfi M, Berlin G, Frey BM, Puig Rovira L, Muniz-Diaz E, Castro E, Chapman C, Green A, Massey E, Win N, Williamson L, Silliman CC, Chaffin DJ, Ambruso DR, Blumberg N, Tomasulo P, Land KJ, Norris PJ, Illoh OC, Davey RJ, Benjamin RJ, Eder AF, McLaughlin L, Kleinman S and Panzer S. Measures to prevent transfusion-related acute lung injury (TRALI). Vox Sang. 2012;103(3):231-59. PM: 22519920

​Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Hourfar MK, Michel P, Offergeld R, Pichl L, Schmidt M, Schottstedt V, Seifried E, Wagner F, Weber-Schehl M, Politis C, Lin CK, Tsoi WC, O’Riordan J, Gottreich A, Shinar E, Yahalom V, Velati C, Satake M, Sanad N, Sisene I, Bon AH, Koppelmann M, Flanagan P, Flesland O, Brojer E, Letowska M, Nascimento F, Zhiburt E, Chua SS, Teo D, Stezinar SL, Vermeulen M, Reddy R, Park Q, Castro E, Eiras A, Gonzales Fraile I, Torres P, Ekermo B, Niederhauser C, Chen H, Oota S, Brant LJ, Eglin R, Jarvis L, Mohabir L, Brodsky J, Foster G, Jennings C, Notari E, Stramer S, Kessler D, Hillyer C, Kamel H, Katz L, Taylor C, Panzer S and Reesink HW. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang. 2012;102(1):82-90. PM: 21933190

Saastamoinen KP, Auvinen MK and Tienari PJ. Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland. Mult Scler J. 2012;18(5):563-8. PM: 2204109

Sainio S, Kuosmanen M. Vastasyntyneen hemolyyttinen tauti ei ole hävinnyt Suomesta. Duodecim 2012;128(2):151-7

Sivula J, Cordova ZM, Tuimala J, Jaatinen T, Partanen J, Volin L and Turpeinen H. Toll-like receptor gene polymorphisms confer susceptibility to graft-versus-host disease in allogenic hematopoietic stem cell transplantation. Scand J Immunol. 2012;76(3):336-41. PM: 22703024

Varney MD, Castley AS, Haimila K and Saavalainen P. Methods for Diagnostic HLA Typing in Disease Association and Drug Hypersensitivity. Methods Mol Biol. 2012;882:27-46. PM: 22665227